Resolution Therapeutics is a biotechnology company that develops macrophage cell therapy to treat inflammatory organ disease.
$84.3M
Oct 02, 2024
-
Yellowstone is an England-based biotechnology company that researches and develops bispecific T-cell receptor therapies for the treatment of cancer.
$21M
Jun 19, 2024
-
iOnctura is a Switzerland-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
$85.9M
Jun 19, 2024
-
Beacon Therapeutics is an England-based biotechnology company that researches and develops ophthalmic gene therapies for the treatment of patients with retinal diseases.
$170M
Jun 11, 2023
-
Frequently Asked Questions about Syncona
What is Syncona investing in?
Syncona has invested in 31 companies including Purespring Therapeutics, Resolution Therapeutics and Yellowstone
What company did Syncona invest in?
Syncona invested in a total 31 companies including Purespring Therapeutics, Resolution Therapeutics and Yellowstone
What are the top 5 investments by Syncona?
The top companies in which Syncona invested are Purespring Therapeutics, Resolution Therapeutics, Yellowstone, iOnctura and Beacon Therapeutics
